Protegrin-2, a potential inhibitor for targeting SARS-CoV-2 main protease M(pro)

BACKGROUND: SARS-CoV-2 variants continue to spread throughout the world and cause waves of COVID-19 infections. It is important to find effective antiviral drugs to combat SARS-CoV-2 and its variants. The main protease (M(pro)) of SARS-CoV-2 is a promising therapeutic target due to its crucial role...

Descripción completa

Detalles Bibliográficos
Autores principales: Jan, Zainab, Geethakumari, Anupriya M., Biswas, Kabir H., Jithesh, Puthen Veettil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412832/
https://www.ncbi.nlm.nih.gov/pubmed/37576748
http://dx.doi.org/10.1016/j.csbj.2023.07.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412832/
https://www.ncbi.nlm.nih.gov/pubmed/37576748
http://dx.doi.org/10.1016/j.csbj.2023.07.020

Ejemplares similares